Pfizer is planning to ask the Food and Drug Administration to authorize a second COVID-19 booster shot for people 65 and older.
A staff member poses with a vial of Pfizer-BioNTech COVID-19 vaccine at a vaccination health center.
The companies plan to seek emergency authorization for this additional booster for older adults to strengthen protections against the omicron variant, according to two people familiar with the situation. Evidence has been mounting that the protection from three shots has faded with time, especially against the omicron variant which is better at evading the immune system than previous versions of the coronavirus.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Pfizer-BioNTech will seek authorization for second COVID booster for older adultsPfizer and BioNTech are planning to ask the Food and Drug Administration to authorize a second COVID-19 booster shot for people age 65 and older.
Lire la suite »
Pfizer/BioNTech seek FDA authorization for fourth Covid-19 vaccine doses for people 65 and upPfizer and BioNTech submitted an application for emergency use authorization to the US Food and Drug Administration for an additional booster dose of their Covid-19 vaccine for adults 65 and older who have gotten a booster dose of any of the authorized or approved vaccine, the companies said Tuesday.
Lire la suite »
Pfizer seeks authorization for 2nd COVID-19 booster for older adultsPfizer's CEO confirmed on Twitter that they seek emergency use authorization to provide a second COVID-19 booster shot for adults 65 years and older.
Lire la suite »
Pfizer to reportedly seek authorization for 2nd COVID-19 booster for older adultsPfizer will seek emergency use authorization to provide a second COVID-19 booster shot for adults 65 years and older, multiple media outlets are reporting.
Lire la suite »
Pfizer to seek authorization for 2nd Covid booster for people 65 and olderIf the FDA authorizes it, the additional shot would go to people who are among those with the highest risk of serious illness.
Lire la suite »
AP source: Pfizer seeking OK for 4th COVID dose for seniorsDrugmaker Pfizer is expected to request authorization this week for an additional COVID-19 booster dose for seniors, according to a person familiar with the matter.
Lire la suite »